MedPath

Adductor Canal Block Versus Patient Controlled Analgesia, in the Surgical Stress Response for Anterior Cruciate Ligament Repair

Phase 1
Withdrawn
Conditions
Anesthesia
Surgery
Stress, Physiological
Interventions
Device: Morphine Patient Controlled Analgesia
Procedure: Adductor Canal Block
Registration Number
NCT04797546
Lead Sponsor
Pontificia Universidad Catolica de Chile
Brief Summary

To evaluate the surgical stress response in anterior cruciate ligament repair with an adductor canal block versus patient controlled endovenous analgesia.

Detailed Description

Preoperative, 2 hours and 24 hours stress biomarkers will be evaluated in two groups of patients, continous adductor canal block and morphine patient controlled endovenous analgesia.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
Male
Target Recruitment
Not specified
Inclusion Criteria
  • Male,
  • 18-65 years,
  • traumatic Anterior Cruciate Ligament tear, scheduled for elective arthroscopic repair with Semitendinous-Gracillis technique at first time in the morning, with full articular range,
  • no other traumatologic lesions.
Exclusion Criteria
  • denied consent to participate,
  • chronic steroids user,
  • diabetes type 1 or 2,
  • insulin resistance,
  • concurrent infectious disease,
  • cognitive failure, coagulopathy,
  • allergy to study drugs,
  • surgery scheduled in the afternoon

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Patient Controlled Morphine AnalgesiaMorphine Patient Controlled AnalgesiaPatients are placed under General Anesthesia, and after surgery, a Morphine patient controlled analgesia delivery system is installed. Preoperative, 2 hours and 24 hours stress biomarkers and analgesic quality will be measured.
Adductor Canal BlockAdductor Canal BlockWith mild sedation, a continous bupivacaine 0.1% infusion catheter is placed in the adductor canal. Afterwards, patients are placed under General Anesthesia, and surgery starts. Preoperative, 2 hours and 24 hours stress biomarkers and analgesic quality will be measured.
Primary Outcome Measures
NameTimeMethod
Change of Blood Cortisol from baseline to 24 hours24 hours

Blood Cortisol will be evaluated preoperatively, 2 hours and 24 hours postoperatively.

Secondary Outcome Measures
NameTimeMethod
Change of Glycemia from baseline to 24 hours24 hours

Glycemia will be evaluated preoperatively, 2 hours and 24 hours postoperatively.

Change of C Reactive Protein from baseline to 24 hours24 hours

C Reactive Protein will be evaluated preoperatively, 2 hours and 24 hours postoperatively.

Trial Locations

Locations (1)

Pontificia Universidad Católica de Chile

🇨🇱

Santiago, Chile

© Copyright 2025. All Rights Reserved by MedPath